Studies by Yao et al. revealed that TP73-AS1 competitively interacts with mitochondrial transcription factor A (TFAM) for miR-200a binding, which amplifies TFAM expression and subsequently drives the proliferation of breast cancer cells [38]. Here, TP73 is linked to breast carcinoma.